Top Markets
Coin of the day
InnoCan Pharma Corporation InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO
Rank in Stocks #33466
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Share Price
$1.69
Last synced: 2026-08-13
Market Cap
$7.59M
Change (1 day)
2.22%
Change (1 year)
-84.04%
Country
CA
Trade InnoCan Pharma Corporation (INNO)

Category

Number of shares outstanding for InnoCan Pharma Corporation (INNO)
Number of shares outstanding as of August 2026: 0
According to InnoCan Pharma Corporation latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for InnoCan Pharma Corporation (INNO) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors